Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Dec:111:104981.
doi: 10.1016/j.oraloncology.2020.104981. Epub 2020 Aug 29.

Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections

Carole Fakhry  1 , Nicholas Fung  2 , Sakshi R Tewari  3 , Gypsyamber D'Souza  4
Affiliations
Multicenter Study

Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections

Carole Fakhry et al. Oral Oncol. 2020 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proportion of oncogenic oral HPV infections that are HPV16 versus other non-HPV16 oncogenic types among OPSCC cancer patients (PROVE study) and the general US populations ages 18–69 (NHANES) Databases. Non-HPV16 oncogenic types included 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.
See this image and copyright information in PMC

References

    1. Fakhry C, Krapcho M, Eisele DW, D’Souza G. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals. Cancer. 2018. 15;124(10):2125–33. - PMC - PubMed
    1. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2015. October 10;33(29):3235–42. - PMC - PubMed
    1. D’Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol Off J Eur Soc Med Oncol. 2017. December 1;28(12):3065–9. - PMC - PubMed
    1. D’Souza G, Clemens G, Troy T, Castillo RG, Struijk L, Waterboer T, et al. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer. Cancer Prev Res Phila Pa. 2019;12(10):689–700. - PMC - PubMed
    1. Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, et al. Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer. JAMA Oncol. 2016. May 1;2(5):599–606. - PMC - PubMed